Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Non-Current Assets (2022 - 2024)

Adial Pharmaceuticals' Non-Current Assets history spans 3 years, with the latest figure at $3.5 million for Q3 2024.

  • For Q3 2024, Non-Current Assets rose 4.1% year-over-year to $3.5 million; the TTM value through Sep 2024 reached $3.5 million, up 4.1%, while the annual FY2023 figure was $3.3 million, 253.02% up from the prior year.
  • Non-Current Assets for Q3 2024 was $3.5 million at Adial Pharmaceuticals, down from $3.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.8 million in Q1 2024 and bottomed at $937028.0 in Q1 2023.
  • The 3-year median for Non-Current Assets is $1.7 million (2023), against an average of $2.2 million.
  • The largest annual shift saw Non-Current Assets decreased 6.17% in 2023 before it surged 308.75% in 2024.
  • A 3-year view of Non-Current Assets shows it stood at $948392.0 in 2022, then soared by 253.02% to $3.3 million in 2023, then rose by 4.74% to $3.5 million in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Non-Current Assets are $3.5 million (Q3 2024), $3.8 million (Q2 2024), and $3.8 million (Q1 2024).